CAS 20971-53-3
:7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2-hydroxyethyl)-
- 2H-1,4-benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2-hydroxyethyl)-
- 7-Chloro-1-(2-hydroxyethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2-hydroxyethyl)-2H-1,4-benzodiazepin-2-one
- N<sup>1</sup>-(2-Hydroxyethyl)flurazepam
- Ro 07-2750
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
2-Hydroxyethylflurazepam, 1mg/ml in Methanol
CAS:Formula:C17H14ClFN2O2Color and Shape:ColourlessMolecular weight:332.762-Hydroxyethylflurazepam, 1mg/ml in Methanol
CAS:Formula:C17H14ClFN2O2Color and Shape:ColourlessMolecular weight:332.762-Hydroxyethylflurazepam 1.0 mg/ml in methanol
CAS:Controlled Product2-Hydroxyethylflurazepam is a metabolite of flurazepam, triazolam, and lorazepam. It is a benzodiazepine that has been shown to be an active metabolite in urine samples. The systematic identification of 2-hydroxyethylflurazepam in urine samples was achieved by the use of mass spectrometric techniques and comparison with data from a library of systematically prepared standards. The metabolites were extracted from urine samples using methanol and incubated at 37°C for 24 hours. The conjugates were then separated by chromatography on a C18 column with water/acetonitrile as the eluant. Matrix effects were minimized by derivatizing with trimethylsilyl chloride before analysis by gas chromatography-mass spectrometry (GCMS) using electron impact ionization (EI). Spectrometric data were obtained by measuring the intensity at m/z values
Formula:C17H14ClFN2O2Purity:Min. 95%Molecular weight:332.8 g/molRef: 3D-VAA97153
Discontinued product



